Table 4.
Comparison of PAM50 subtypes pre- and post-neoadjuvant chemotherapy (GSE32072).
| Post-Therapy | ||||||
|---|---|---|---|---|---|---|
| Basal | HER2 | LumA | LumB | Normal | ||
| Pre-therapy | Basal | 5 | 0 | 0 | 0 | 0 |
| HER2 | 0 | 4 | 0 | 0 | 0 | |
| LumA | 0 | 0 | 5 | 1 | 0 | |
| LumB | 0 | 0 | 0 | 1 | 0 | |
| Normal | 2 | 1 | 1 | 0 | 1 | |
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.